George Somlo

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

77h-index31.3kcitations545works3.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(124), Multiple Myeloma Research and Treatments(97), Breast Cancer Treatment Studies(89), HER2/EGFR in Cancer Research(79), Advanced Breast Cancer Therapies(61)

Publications544 total

Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer
2025Open Access
Abstract GS3-10: Paired DNA and RNA analysis of CALGB 40603 (Alliance) reveals insights into the molecular and prognostic landscape of stage II-III triple-negative breast cancer
Clinical Cancer Research·2025
Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets
UNC Libraries·2025Open Access
Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets
npj Breast Cancer·2025· 4 citedOpen Access
Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702
Leukemia·2025· 3 cited
24-Hour Urine Testing Does Not Add Value to Multiple Myeloma Response Assessments: A Secondary Analysis of BMT CTN 0702
Blood·2024· 6 cited
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
UNC Libraries·2024Open Access
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival
Journal of Clinical Oncology·2024· 14 citedOpen Access
Phase 1 Study of Bortezomib, Fludarabine, and Melphalan, With or Without Total Marrow Irradiation, as Allogeneic Hematopoietic Stem Cell Transplant Conditioning for High-risk or Relapsed/Refractory Multiple Myeloma
American Journal of Clinical Oncology·2024· 1 cited
Phase I Study of Bortezomib, Fludarabine, and Melphalan, with or without Total Marrow Irradiation as Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Relapsed/Refractory Multiple Myeloma
International Journal of Radiation Oncology*Biology*Physics·2023Open Access
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer
Cancer Immunology Immunotherapy·2023· 18 citedOpen Access
Supplementary Figure 1 from TGFβ Induces “BRCAness” and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes
2023Open Access
Data from TGFβ Induces “BRCAness” and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes
2023Open Access
Supplementary Figure 1 from TGFβ Induces “BRCAness” and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes
2023Open Access
Data from TGFβ Induces “BRCAness” and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes
2023Open Access
Supplementary Materials and Methods, Figure Legend from TGFβ Induces “BRCAness” and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes
2023Open Access
Supplementary Materials and Methods, Figure Legend from TGFβ Induces “BRCAness” and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes
2023Open Access
Data from Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis
2023Open Access
Figure S1 from Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis
2023Open Access
Supplementary Data from Protein Kinase A Activation Confers Resistance to Trastuzumab in Human Breast Cancer Cell Lines
2023Open Access
page 1 of 28Next →

Frequent Co-authors

William J. Gradishar(11), Harold J. Burstein(11), Clifford A. Hudis(11), Lori J. Goldstein(10), Benjamin O. Anderson(9), William B. Farrar(9), Ingrid A. Mayer(9), Beryl McCormick(9), Lori J. Pierce(9), Elizabeth Reed(9), John H. Ward(9), Rashmi Kumar(9), Lee S. Schwartzberg(8), Antonio C. Wolff(8), Andres Forero(8), Sharon H. Giordano(8), Mary Lou Smith(8), Dorothy A. Shead(8), Steven J. Isakoff(7), Hatem Soliman(7)